XML 80 R14.htm IDEA: XBRL DOCUMENT
v3.23.2

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Numerator: |  |  |  |  |  |  |
Net income (loss) attributable to Surgery Partners, Inc. | $ | 18.9 |  |  | $ | (18.4) |  |  | $ | (6.0) |  |  | $ | (6.2) |
Denominator: |  |  |  |  |  |  |
Weighted average shares outstanding- basic | 125,718 |  |  | 88,900 |  |  | 125,463 |  |  | 88,450 |
Weighted average shares outstanding- diluted (1) | 127,370 |  |  | 88,900 |  |  | 125,463 |  |  | 88,450 |
Income (loss) per share: |  |  |  |  |  |  |
Basic | $ | 0.15 |  |  | $ | (0.21) |  |  | $ | (0.05) |  |  | $ | (0.07) |
Diluted (1) | $ | 0.15 |  |  | $ | (0.21) |  |  | $ | (0.05) |  |  | $ | (0.07) |
Dilutive securities outstanding not included in the computation of income (loss) per share as their effect is antidilutive: |  |  |  |  |  |  |
Stock options | — |  |  | 1,559 |  |  | 1,407 |  |  | 1,599 |
Restricted shares | — |  |  | 628 |  |  | 147 |  |  | 644 |
(1)The impact of potentially dilutive securities for the three months ended June 30, 2022 and the six months ended June 30, 2023 and 2022, was not considered because the effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration